Agios Pharmaceuticals reported $0 in Equity Capital and Reserves for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 421M 8M
Alexion Pharmaceuticals ALXN:US $ 10490.8M 1257M
Alnylam Pharmaceuticals ALNY:US $ 1215.02M 184.7M
Amgen AMGN:US $ 10659M 1174M
AstraZeneca AZN:LN 12195M 42M
Bayer BAYN:GR € 35704M 12905M
Biogen BIIB:US $ 10758.5M 550.2M
Biomarin Pharmaceutical BMRN:US $ 3236.68M 3.28M
Bluebird Bio BLUE:US $ 1682.03M 561.6M
Bristol Myers Squibb BMY:US $ 49094M 817M
Daiichi Sankyo 4568:JP Y 1315678M 9868M
Eli Lilly And LLY:US $ 4092.9M 1014.1M
Exelixis EXEL:US $ 1833M 86M
Gilead Sciences GILD:US $ 18027M 4040M
GlaxoSmithKline GSK:LN 13593M 499M
Immunogen IMGN:US $ -42.89M 18.37M
JAZZ PHA JAZZ:US $ 3377.2M 235.4M
Merk MRK:US $ 27642M 1437M
Novartis NVS:US $ 54484M 672M
Pfizer PFE:US $ 64336M 690M
Puma Biotechnology PBYI:US $ 23M 14M
Regeneron Pharmaceuticals REGN:US $ 9057.4M 3075.6M
Sarepta Therapeutics SRPT:US $ 1042M 102M
Seattle Genetics SGEN:US $ 2258.03M 443.95M
Vertex Pharmaceuticals VRTX:US $ 7519.24M 1057.59M
YTE INCY:US $ 2344.6M 406.88M